FDA.reportPublic FDA data

Application 202560

Type
ANDA
Sponsor
GLENMARK GENERICS

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001ZOLMITRIPTANZOLMITRIPTANTABLET, ORALLY DISINTEGRATING;ORAL2.5MGNoNo
002ZOLMITRIPTANZOLMITRIPTANTABLET, ORALLY DISINTEGRATING;ORAL5MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
68462-499zolmiptriptanzolmitriptanGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-499zolmiptriptanzolmitriptanGlenmark Pharmaceuticals ANDACurrent
68462-499zolmiptriptanzolmitriptanGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-499zolmiptriptanzolmitriptanGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-499zolmiptriptanzolmitriptanGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-500zolmiptriptanzolmitriptanGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-500zolmiptriptanzolmitriptanGlenmark Pharmaceuticals ANDACurrent
68462-500zolmiptriptanzolmitriptanGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-500zolmiptriptanzolmitriptanGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-500zolmiptriptanzolmitriptanGlenmark Pharmaceuticals Inc., USAANDACurrent